Celiac & Gluten Sensitivity (DBS)

Overview

The Celiac & Gluten Sensitivity (DBS) test evaluates the presence of IgA and IgG antibodies related to gliadin and deamidated gliadin peptides using a dried blood spot sample. This approach offers insight into immune system interactions with gluten-associated proteins. The test is designed to support understanding of individual responses to gluten consumption and can provide information relevant to digestive health, nutrient absorption, and overall wellbeing.

This assessment may be informative for those interested in exploring factors related to digestive comfort, nutrient balance, skin health, energy levels, or general wellness. It offers a broader picture by considering multiple antibody markers linked to gluten proteins, which can contribute to lifestyle and nutritional discussions. Interpreting these findings alongside dietary habits, symptom patterns, nutrient levels, and personal or family health interests can enhance awareness and guide lifestyle considerations.

Practitioners and individuals may use the Celiac & Gluten Sensitivity (DBS) test results as part of a comprehensive overview of gluten-related immune activity. This information can contribute to a better understanding of individual responses to gluten and support informed decisions related to diet and wellness strategies. Combining antibody insights with other factors helps create a nuanced perspective of personal health and wellness trends associated with gluten intake.

Celiac & Gluten Sensitivity (DBS) is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. Celiac & Gluten Sensitivity (DBS) is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.